1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carreras, A; Cascante, M; Costoya, N; Fernández-Cachón, ML; Mateos-Martín, ML; Moyer, MP; Nuñez, MJ; Sánchez-Tena, S; Torres, JL | 1 |
| Kang, YR; Kawk, SH; Kim, YH | 1 |
| Lau, CB; Leung, PC; Wong, CK; Yang, H; Yue, GG; Zhang, YJ | 1 |
3 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Colonic Neoplasms
| Article | Year |
|---|---|
Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Colonic Neoplasms; Drug Screening Assays, Antitumor; Gallic Acid; Hamamelis; Hexoses; Humans; Hydrogen Peroxide; Hydrolyzable Tannins; Molecular Structure; Plant Bark | 2012 |
1,2,3,4,6-Penta-O-galloyl-β-d-glucose suppresses colon cancer through induction of tumor suppressor.
Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrolyzable Tannins; Molecular Structure; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2018 |
Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
Topics: Actin Depolymerizing Factors; Animals; Bromodeoxyuridine; Cathepsin B; Cell Line, Tumor; Colonic Neoplasms; Extracellular Matrix; Glucose; Humans; Hydrolyzable Tannins; Interleukin-10; Interleukin-2; Interleukin-6; Mice; Tumor Necrosis Factor-alpha | 2022 |